Rolf Barth to Tacrolimus
This is a "connection" page, showing publications Rolf Barth has written about Tacrolimus.
Connection Strength
0.674
-
Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Transplantation. 2009 Dec 15; 88(11):1242-50.
Score: 0.321
-
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant. 2011 Jul; 11(7):1407-16.
Score: 0.089
-
Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival. Plast Reconstr Surg. 2009 Feb; 123(2):493-501.
Score: 0.076
-
Impact of Renal Replacement Therapy on Rejection among Liver Transplant Recipients. Prog Transplant. 2023 Dec; 33(4):348-355.
Score: 0.053
-
Impact of Steroid Only Induction on Rejection in Simultaneous Liver-Kidney Transplantation. Prog Transplant. 2022 Dec; 32(4):363-369.
Score: 0.048
-
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation. 2001 May 27; 71(10):1368-79.
Score: 0.044
-
Tolerance across a two-haplotype, fully MHC-mismatched barrier induced in miniature swine renal allografts treated with a 12-day course of tacrolimus. Transplant Proc. 2001 Feb-Mar; 33(1-2):101.
Score: 0.043